» Articles » PMID: 29343833

Dopamine D3 Receptor Antagonist Reveals a Cryptic Pocket in Aminergic GPCRs

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jan 19
PMID 29343833
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The recent increase in the number of X-ray crystal structures of G-protein coupled receptors (GPCRs) has been enabling for structure-based drug design (SBDD) efforts. These structures have revealed that GPCRs are highly dynamic macromolecules whose function is dependent on their intrinsic flexibility. Unfortunately, the use of static structures to understand ligand binding can potentially be misleading, especially in systems with an inherently high degree of conformational flexibility. Here, we show that docking a set of dopamine D3 receptor compounds into the existing eticlopride-bound dopamine D3 receptor (D3R) X-ray crystal structure resulted in poses that were not consistent with results obtained from site-directed mutagenesis experiments. We overcame the limitations of static docking by using large-scale high-throughput molecular dynamics (MD) simulations and Markov state models (MSMs) to determine an alternative pose consistent with the mutation data. The new pose maintains critical interactions observed in the D3R/eticlopride X-ray crystal structure and suggests that a cryptic pocket forms due to the shift of a highly conserved residue, F. Our study highlights the importance of GPCR dynamics to understand ligand binding and provides new opportunities for drug discovery.

Citing Articles

Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.

Shenol A, Tenente R, Luckmann M, Frimurer T, Schwartz T Nat Commun. 2024; 15(1):5364.

PMID: 38918366 PMC: 11199501. DOI: 10.1038/s41467-024-49536-y.


Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells.

Mattheisen J, Limberakis C, Ruggeri R, Dowling M, Am Ende C, Ceraudo E J Am Chem Soc. 2023; 145(20):11173-11184.

PMID: 37116188 PMC: 10214443. DOI: 10.1021/jacs.3c00972.


Activation mechanism of the human Smoothened receptor.

Bansal P, Dutta S, Shukla D Biophys J. 2023; 122(7):1400-1413.

PMID: 36883002 PMC: 10111369. DOI: 10.1016/j.bpj.2023.03.007.


Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence.

Noonan T, Denzinger K, Talagayev V, Chen Y, Puls K, Wolf C Pharmaceuticals (Basel). 2022; 15(11).

PMID: 36355476 PMC: 9695541. DOI: 10.3390/ph15111304.


Approach to the specificity and selectivity between D2 and D3 receptors by mutagenesis and binding experiments part I: Expression and characterization of D2 and D3 receptor mutants.

Legros C, Rojas A, Dupre C, Brasseur C, Riest-Fery I, Muller O Protein Sci. 2022; 31(12):e4459.

PMID: 36177735 PMC: 9667827. DOI: 10.1002/pro.4459.


References
1.
Wescott M, Kufareva I, Paes C, Goodman J, Thaker Y, Puffer B . Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices. Proc Natl Acad Sci U S A. 2016; 113(35):9928-33. PMC: 5024644. DOI: 10.1073/pnas.1601278113. View

2.
Friesner R, Murphy R, Repasky M, Frye L, Greenwood J, Halgren T . Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006; 49(21):6177-96. DOI: 10.1021/jm051256o. View

3.
Plattner N, Noe F . Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models. Nat Commun. 2015; 6:7653. PMC: 4506540. DOI: 10.1038/ncomms8653. View

4.
Zanatta G, Nunes G, Bezerra E, da Costa R, Martins A, Caetano E . Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines. ACS Chem Neurosci. 2014; 5(10):1041-54. DOI: 10.1021/cn500111e. View

5.
Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D . Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49. DOI: 10.1021/jm0306430. View